Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The "Inflammatory Bowel Disease - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.
This report provides top line data relating to the clinical trials on Inflammatory Bowel Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.
Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). These Clinical Trial Reports are generated using the analyst's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Key Topics Covered:
- Report Guidance
- The analyst Clinical Trials Report Coverage
- Clinical Trials by Region
- Clinical Trials and Average Enrollment by Country
- Top Five Countries Contributing to Clinical Trials in Asia-Pacific
- Top Five Countries Contributing to Clinical Trials in Europe
- Top Countries Contributing to Clinical Trials in North America
- Top Five Countries Contributing to Clinical Trials in Middle East and Africa
- Top Five Countries Contributing to Clinical Trials in Central and South America
- Clinical Trials by G7 Countries: Proportion of Inflammatory Bowel Disease to Gastrointestinal Clinical Trials
- Clinical Trials by Phase in G7 Countries
- Clinical Trials in G7 Countries by Trial Status
- Clinical Trials by E7 Countries: Proportion of Inflammatory Bowel Disease to Gastrointestinal Clinical Trials
- Clinical Trials by Phase in E7 Countries
- Clinical Trials in E7 Countries by Trial Status
- Clinical Trials by Phase
- In Progress Trials by Phase
- Clinical Trials by Trial Status
- Clinical Trials by End Point Status
- Subjects Recruited Over a Period of Time
- Clinical Trials by Sponsor Type
- Prominent Sponsors
- Top Companies Participating in Inflammatory Bowel Disease Therapeutics Clinical Trials
- Prominent Drugs
- Latest Clinical Trials News on Inflammatory Bowel Disease
- Aug 21, 2025: Shattuck Labs Announces IND for SL-325 Is in Effect for the Treatment of Inflammatory Bowel Disease
- Jul 17, 2025: Guselkumab Demonstrates Superior Efficacy in Landmark Clinical Trials and Offers New Hope to Crohn's Disease Patients
- Jul 10, 2025: Earendil Labs Announces Initiation of a Phase 1 Study of a Half-Life Extended Novel Anti-TL1A Antibody
- Jun 16, 2025: Spyre to Host Conference Call to Report Phase 1 Trials Results for SPY002 Program, its Novel Half-Life Extended Anti-TL1A Antibodies on June 17, 2025
- Clinical Trial Profile Snapshots
- Appendix
Companies Featured
- Takeda Pharmaceutical Co Ltd
- AbbVie Inc
- Pfizer Inc
- Johnson & Johnson
- ICON Plc
- Thermo Fisher Scientific Inc
- Labcorp Holdings Inc
- The Alimentiv Health Trust
- IQVIA Holdings Inc
- Bristol-Myers Squibb Co
For more information about this clinical trials report visit https://www.researchandmarkets.com/r/ir8v8m
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
